FI943295A - Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit - Google Patents
Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit Download PDFInfo
- Publication number
- FI943295A FI943295A FI943295A FI943295A FI943295A FI 943295 A FI943295 A FI 943295A FI 943295 A FI943295 A FI 943295A FI 943295 A FI943295 A FI 943295A FI 943295 A FI943295 A FI 943295A
- Authority
- FI
- Finland
- Prior art keywords
- extracts
- formulations containing
- thonningii
- piliostigma
- piliostigma thonningii
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI941135A IT1269880B (it) | 1994-06-01 | 1994-06-01 | Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono |
Publications (2)
Publication Number | Publication Date |
---|---|
FI943295A0 FI943295A0 (fi) | 1994-07-11 |
FI943295A true FI943295A (fi) | 1995-12-02 |
Family
ID=11369029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI943295A FI943295A (fi) | 1994-06-01 | 1994-07-11 | Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit |
Country Status (15)
Country | Link |
---|---|
US (1) | US5635185A (fi) |
EP (1) | EP0685235B1 (fi) |
JP (1) | JPH07330788A (fi) |
KR (1) | KR100235685B1 (fi) |
AT (1) | ATE189604T1 (fi) |
AU (1) | AU684781B2 (fi) |
CA (1) | CA2127762A1 (fi) |
DE (2) | DE69422980T2 (fi) |
DK (1) | DK0685235T3 (fi) |
ES (1) | ES2081782T3 (fi) |
FI (1) | FI943295A (fi) |
GR (2) | GR960300005T1 (fi) |
HK (1) | HK1012567A1 (fi) |
IT (1) | IT1269880B (fi) |
PT (1) | PT685235E (fi) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003026636A (ja) * | 2001-07-10 | 2003-01-29 | Gekkeikan Sake Co Ltd | 脂質代謝系酵素を阻害するチロゾール誘導体 |
CN108619178B (zh) * | 2018-06-08 | 2021-04-09 | 临沂大学 | 一种具有抗病毒作用的忍冬藤菇提取物及其制备方法和应用 |
-
1994
- 1994-06-01 IT ITMI941135A patent/IT1269880B/it active IP Right Grant
- 1994-07-11 CA CA002127762A patent/CA2127762A1/en not_active Abandoned
- 1994-07-11 FI FI943295A patent/FI943295A/fi unknown
- 1994-07-13 EP EP94110861A patent/EP0685235B1/en not_active Expired - Lifetime
- 1994-07-13 PT PT94110861T patent/PT685235E/pt unknown
- 1994-07-13 AT AT94110861T patent/ATE189604T1/de not_active IP Right Cessation
- 1994-07-13 US US08/274,407 patent/US5635185A/en not_active Expired - Fee Related
- 1994-07-13 DE DE69422980T patent/DE69422980T2/de not_active Expired - Fee Related
- 1994-07-13 DK DK94110861T patent/DK0685235T3/da active
- 1994-07-13 ES ES94110861T patent/ES2081782T3/es not_active Expired - Lifetime
- 1994-07-13 DE DE0685235T patent/DE685235T1/de active Pending
- 1994-07-15 AU AU67517/94A patent/AU684781B2/en not_active Ceased
- 1994-07-25 JP JP6172543A patent/JPH07330788A/ja active Pending
-
1995
- 1995-05-30 KR KR1019950013949A patent/KR100235685B1/ko not_active IP Right Cessation
-
1996
- 1996-02-29 GR GR960300005T patent/GR960300005T1/el unknown
-
1998
- 1998-12-17 HK HK98113938A patent/HK1012567A1/xx not_active IP Right Cessation
-
2000
- 2000-02-10 GR GR20000400290T patent/GR3032621T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1012567A1 (en) | 1999-08-06 |
EP0685235A1 (en) | 1995-12-06 |
FI943295A0 (fi) | 1994-07-11 |
DK0685235T3 (da) | 2000-06-19 |
ES2081782T3 (es) | 2000-07-01 |
EP0685235B1 (en) | 2000-02-09 |
AU684781B2 (en) | 1998-01-08 |
JPH07330788A (ja) | 1995-12-19 |
PT685235E (pt) | 2000-05-31 |
DE69422980D1 (de) | 2000-03-16 |
KR960000244A (ko) | 1996-01-25 |
CA2127762A1 (en) | 1995-12-02 |
KR100235685B1 (ko) | 2000-02-01 |
AU6751794A (en) | 1996-01-04 |
GR960300005T1 (en) | 1996-02-29 |
ITMI941135A0 (it) | 1994-06-01 |
US5635185A (en) | 1997-06-03 |
ES2081782T1 (es) | 1996-03-16 |
IT1269880B (it) | 1997-04-15 |
ATE189604T1 (de) | 2000-02-15 |
GR3032621T3 (en) | 2000-05-31 |
DE69422980T2 (de) | 2000-08-17 |
DE685235T1 (de) | 1996-10-10 |
ITMI941135A1 (it) | 1995-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY107843A (en) | Anti-viral compounds. | |
EA199901031A1 (ru) | Производные бензимидазола | |
ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
FI904445A0 (fi) | Antivirala foereningar. | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
ES2125976T3 (es) | Otros derivados de indol con accion antiviral. | |
BR9711647A (pt) | Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os. | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
PT777669E (pt) | Utilizacao de succinato de 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral | |
DE69403063D1 (de) | Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen | |
MX9301922A (es) | Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv). | |
DK178188D0 (da) | Antivirusmiddel | |
FI943295A (fi) | Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit | |
TR199900523T2 (xx) | Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler. | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
ES2078380T3 (es) | Oligofosfatos de accion antiviral. | |
ES2140329B1 (es) | Utilizacion de acido maslinico como inhibidor de proteasas para el tratamiento de la enfermedad causada por los virus de la inmunodeficiencia adquirida. | |
BR9708720A (pt) | Composição farmacêutica e processo para o tratamento de demência por hiv. | |
RU93004467A (ru) | Замещенные пуриновые арабинозы, их применение, фармацевтическая композиция |